stars 1 stars 2 stars 3

RedPath Integrated Pathology is a Pittsburgh-based molecular diagnostics laboratory focused on providing novel solutions for clinicians. Our patented PathFinderTG® platform produces mutational profiles to help physicians resolve complex diagnostic dilemmas in patients who are at risk of cancer. RedPath performs all clinical testing and R&D in its state-of-the-art, CLIA-certified and CAP-accredited laboratory. RedPath’s platform is supported by over 20 years of scientific and clinical research, and studies using it have been published in over 200 peer-reviewed journals including the New England Journal of Medicine. Two recent healthcare economic studies demonstrate that the use of PathFinderTG significantly reduces healthcare costs. Based on the strong clinical data supporting our platform, RedPath has received positive coverage decisions from Medicare and several private payers. RedPath is committed to offering cutting-edge molecular diagnostic services to support gastroenterologists, pathologists, and other physicians by improving clinical management of patients.

RedPath Integrated Pathology Questions

The RedPath Integrated Pathology annual revenue was $8.8 million in 2026.

Joe Donnelly is the CFO of RedPath Integrated Pathology.

11 people are employed at RedPath Integrated Pathology.

RedPath Integrated Pathology is based in Pittsburgh, Pennsylvania.

The NAICS codes for RedPath Integrated Pathology are [621, 62].

The SIC codes for RedPath Integrated Pathology are [8071, 807, 80].

Top RedPath Integrated Pathology Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users